Loading…

The association of serum magnesium with infection in new-onset systemic lupus erythematosus patients

Objective To assess the association of serum magnesium with infection in new-onset systemic lupus erythematosus (SLE) patients. Methods We conducted a single-center retrospective cohort study of new-onset SLE patients from 2012 to 2021. The hospitalized SLE patients were divided into infection and n...

Full description

Saved in:
Bibliographic Details
Published in:Lupus 2023-03, Vol.32 (3), p.380-387
Main Authors: Yang, Wenfang, Lian, Xuejian, Chen, Hongpu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c368t-fe5c1af6f735bec585aaec6ee52ab6e5158986dc14b192c9e04e1f046f3f2d5e3
cites cdi_FETCH-LOGICAL-c368t-fe5c1af6f735bec585aaec6ee52ab6e5158986dc14b192c9e04e1f046f3f2d5e3
container_end_page 387
container_issue 3
container_start_page 380
container_title Lupus
container_volume 32
creator Yang, Wenfang
Lian, Xuejian
Chen, Hongpu
description Objective To assess the association of serum magnesium with infection in new-onset systemic lupus erythematosus (SLE) patients. Methods We conducted a single-center retrospective cohort study of new-onset SLE patients from 2012 to 2021. The hospitalized SLE patients were divided into infection and noninfection groups. Logistic regression analysis was conducted to examine the association of hypomagnesemia with infection. Results A total of 476 new-onset SLE patients were included, with 299 cases in the infection group and 177 cases in the noninfection group. The patients were mostly females (81.7%). The average age at diagnosis was 43.7 years. The median duration was 1.0 month. The prevalence of hypomagnesemia (1.10) in new-onset SLE patients was 14.3%, 83.4%, and 2.3%, respectively. The prevalence of hypomagnesemia was 18.4% in the infection group and 7.3% in the noninfection group (p = .001). The baseline value of serum magnesium was 0.819 mmol/L, with values of 0.799 mmol/L in the infection group and 0.854 mmol/L in the noninfection group (p = .000). The following clinical variables were significantly different between the two groups (p < .05): age, duration, hospitalization stay, fever, serositis, and SLE Disease Activity Index 2000 (SLEDAI 2K). The laboratory parameters, including hemoglobin, white blood cell count, albumin level, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), procalcitonin, and complement C3 were also significantly different between the two groups (p < .05). The mortality was 4.4% (21/476), with 20 cases occurring in the infection group. Logistic regression analysis showed that hypomagnesemia was associated with an increased risk of infection (p = .001) and poor prognosis (p = .015). Conclusion Hypermagnesemia was rare in new-onset SLE patients. Hypomagnesemia was common and was associated with an increased risk of infection in new-onset SLE patients.
doi_str_mv 10.1177/09612033221149884
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2760818547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_09612033221149884</sage_id><sourcerecordid>2760818547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-fe5c1af6f735bec585aaec6ee52ab6e5158986dc14b192c9e04e1f046f3f2d5e3</originalsourceid><addsrcrecordid>eNp10c9LHDEUB_AgFt3a_gG9lIAXL2PzJj8mcxTRWhB6sechm31xIzvJOi-D7H9vtmtbaOkpCe_zvgl5jH0CcQnQdV9Eb6AVUrYtgOqtVUdsAarrmlpoj9liX2_24JS9J3oSQkjozQk7lUb3ugO5YKuHNXJHlH10JebEc-CE0zzy0T0mpFh3L7GseUwB_U8RE0_40uREWDjtqOAYPd_M25k4TruyxtGVTPW0rZGYCn1g74LbEH58W8_Yj9ubh-u75v7712_XV_eNl8aWJqD24IIJndRL9Npq59AbRN26pUEN2vbWrDyoJfSt71EohCCUCTK0K43yjF0ccrdTfp6RyjBG8rjZuIR5pqHtjLBgteoqPf-LPuV5SvV1VVmjFPSgq4KD8lMmmjAM2ymObtoNIIb9CIZ_RlB7Pr8lz8sRV787fv15BZcHQO4R_1z7_8RXrPiQDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2786441915</pqid></control><display><type>article</type><title>The association of serum magnesium with infection in new-onset systemic lupus erythematosus patients</title><source>SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024: Reading List</source><creator>Yang, Wenfang ; Lian, Xuejian ; Chen, Hongpu</creator><creatorcontrib>Yang, Wenfang ; Lian, Xuejian ; Chen, Hongpu</creatorcontrib><description>Objective To assess the association of serum magnesium with infection in new-onset systemic lupus erythematosus (SLE) patients. Methods We conducted a single-center retrospective cohort study of new-onset SLE patients from 2012 to 2021. The hospitalized SLE patients were divided into infection and noninfection groups. Logistic regression analysis was conducted to examine the association of hypomagnesemia with infection. Results A total of 476 new-onset SLE patients were included, with 299 cases in the infection group and 177 cases in the noninfection group. The patients were mostly females (81.7%). The average age at diagnosis was 43.7 years. The median duration was 1.0 month. The prevalence of hypomagnesemia (&lt;0.70), normomagnesemia (0.70–1.10), and hypermagnesemia (&gt;1.10) in new-onset SLE patients was 14.3%, 83.4%, and 2.3%, respectively. The prevalence of hypomagnesemia was 18.4% in the infection group and 7.3% in the noninfection group (p = .001). The baseline value of serum magnesium was 0.819 mmol/L, with values of 0.799 mmol/L in the infection group and 0.854 mmol/L in the noninfection group (p = .000). The following clinical variables were significantly different between the two groups (p &lt; .05): age, duration, hospitalization stay, fever, serositis, and SLE Disease Activity Index 2000 (SLEDAI 2K). The laboratory parameters, including hemoglobin, white blood cell count, albumin level, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), procalcitonin, and complement C3 were also significantly different between the two groups (p &lt; .05). The mortality was 4.4% (21/476), with 20 cases occurring in the infection group. Logistic regression analysis showed that hypomagnesemia was associated with an increased risk of infection (p = .001) and poor prognosis (p = .015). Conclusion Hypermagnesemia was rare in new-onset SLE patients. Hypomagnesemia was common and was associated with an increased risk of infection in new-onset SLE patients.</description><identifier>ISSN: 0961-2033</identifier><identifier>EISSN: 1477-0962</identifier><identifier>DOI: 10.1177/09612033221149884</identifier><identifier>PMID: 36595713</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Adult ; Blood Sedimentation ; C-reactive protein ; C-Reactive Protein - analysis ; Complement component C3 ; Erythrocyte sedimentation rate ; Female ; Hemoglobin ; Humans ; Hypermagnesemia ; Hypomagnesemia ; Infections ; Lupus ; Lupus Erythematosus, Systemic - complications ; Magnesium ; Male ; Procalcitonin ; Regression analysis ; Retrospective Studies ; Serositis ; Systemic lupus erythematosus</subject><ispartof>Lupus, 2023-03, Vol.32 (3), p.380-387</ispartof><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-fe5c1af6f735bec585aaec6ee52ab6e5158986dc14b192c9e04e1f046f3f2d5e3</citedby><cites>FETCH-LOGICAL-c368t-fe5c1af6f735bec585aaec6ee52ab6e5158986dc14b192c9e04e1f046f3f2d5e3</cites><orcidid>0000-0001-6460-9905</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36595713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Wenfang</creatorcontrib><creatorcontrib>Lian, Xuejian</creatorcontrib><creatorcontrib>Chen, Hongpu</creatorcontrib><title>The association of serum magnesium with infection in new-onset systemic lupus erythematosus patients</title><title>Lupus</title><addtitle>Lupus</addtitle><description>Objective To assess the association of serum magnesium with infection in new-onset systemic lupus erythematosus (SLE) patients. Methods We conducted a single-center retrospective cohort study of new-onset SLE patients from 2012 to 2021. The hospitalized SLE patients were divided into infection and noninfection groups. Logistic regression analysis was conducted to examine the association of hypomagnesemia with infection. Results A total of 476 new-onset SLE patients were included, with 299 cases in the infection group and 177 cases in the noninfection group. The patients were mostly females (81.7%). The average age at diagnosis was 43.7 years. The median duration was 1.0 month. The prevalence of hypomagnesemia (&lt;0.70), normomagnesemia (0.70–1.10), and hypermagnesemia (&gt;1.10) in new-onset SLE patients was 14.3%, 83.4%, and 2.3%, respectively. The prevalence of hypomagnesemia was 18.4% in the infection group and 7.3% in the noninfection group (p = .001). The baseline value of serum magnesium was 0.819 mmol/L, with values of 0.799 mmol/L in the infection group and 0.854 mmol/L in the noninfection group (p = .000). The following clinical variables were significantly different between the two groups (p &lt; .05): age, duration, hospitalization stay, fever, serositis, and SLE Disease Activity Index 2000 (SLEDAI 2K). The laboratory parameters, including hemoglobin, white blood cell count, albumin level, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), procalcitonin, and complement C3 were also significantly different between the two groups (p &lt; .05). The mortality was 4.4% (21/476), with 20 cases occurring in the infection group. Logistic regression analysis showed that hypomagnesemia was associated with an increased risk of infection (p = .001) and poor prognosis (p = .015). Conclusion Hypermagnesemia was rare in new-onset SLE patients. Hypomagnesemia was common and was associated with an increased risk of infection in new-onset SLE patients.</description><subject>Adult</subject><subject>Blood Sedimentation</subject><subject>C-reactive protein</subject><subject>C-Reactive Protein - analysis</subject><subject>Complement component C3</subject><subject>Erythrocyte sedimentation rate</subject><subject>Female</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Hypermagnesemia</subject><subject>Hypomagnesemia</subject><subject>Infections</subject><subject>Lupus</subject><subject>Lupus Erythematosus, Systemic - complications</subject><subject>Magnesium</subject><subject>Male</subject><subject>Procalcitonin</subject><subject>Regression analysis</subject><subject>Retrospective Studies</subject><subject>Serositis</subject><subject>Systemic lupus erythematosus</subject><issn>0961-2033</issn><issn>1477-0962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp10c9LHDEUB_AgFt3a_gG9lIAXL2PzJj8mcxTRWhB6sechm31xIzvJOi-D7H9vtmtbaOkpCe_zvgl5jH0CcQnQdV9Eb6AVUrYtgOqtVUdsAarrmlpoj9liX2_24JS9J3oSQkjozQk7lUb3ugO5YKuHNXJHlH10JebEc-CE0zzy0T0mpFh3L7GseUwB_U8RE0_40uREWDjtqOAYPd_M25k4TruyxtGVTPW0rZGYCn1g74LbEH58W8_Yj9ubh-u75v7712_XV_eNl8aWJqD24IIJndRL9Npq59AbRN26pUEN2vbWrDyoJfSt71EohCCUCTK0K43yjF0ccrdTfp6RyjBG8rjZuIR5pqHtjLBgteoqPf-LPuV5SvV1VVmjFPSgq4KD8lMmmjAM2ymObtoNIIb9CIZ_RlB7Pr8lz8sRV787fv15BZcHQO4R_1z7_8RXrPiQDQ</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Yang, Wenfang</creator><creator>Lian, Xuejian</creator><creator>Chen, Hongpu</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6460-9905</orcidid></search><sort><creationdate>202303</creationdate><title>The association of serum magnesium with infection in new-onset systemic lupus erythematosus patients</title><author>Yang, Wenfang ; Lian, Xuejian ; Chen, Hongpu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-fe5c1af6f735bec585aaec6ee52ab6e5158986dc14b192c9e04e1f046f3f2d5e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Blood Sedimentation</topic><topic>C-reactive protein</topic><topic>C-Reactive Protein - analysis</topic><topic>Complement component C3</topic><topic>Erythrocyte sedimentation rate</topic><topic>Female</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Hypermagnesemia</topic><topic>Hypomagnesemia</topic><topic>Infections</topic><topic>Lupus</topic><topic>Lupus Erythematosus, Systemic - complications</topic><topic>Magnesium</topic><topic>Male</topic><topic>Procalcitonin</topic><topic>Regression analysis</topic><topic>Retrospective Studies</topic><topic>Serositis</topic><topic>Systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Wenfang</creatorcontrib><creatorcontrib>Lian, Xuejian</creatorcontrib><creatorcontrib>Chen, Hongpu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Lupus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Wenfang</au><au>Lian, Xuejian</au><au>Chen, Hongpu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The association of serum magnesium with infection in new-onset systemic lupus erythematosus patients</atitle><jtitle>Lupus</jtitle><addtitle>Lupus</addtitle><date>2023-03</date><risdate>2023</risdate><volume>32</volume><issue>3</issue><spage>380</spage><epage>387</epage><pages>380-387</pages><issn>0961-2033</issn><eissn>1477-0962</eissn><abstract>Objective To assess the association of serum magnesium with infection in new-onset systemic lupus erythematosus (SLE) patients. Methods We conducted a single-center retrospective cohort study of new-onset SLE patients from 2012 to 2021. The hospitalized SLE patients were divided into infection and noninfection groups. Logistic regression analysis was conducted to examine the association of hypomagnesemia with infection. Results A total of 476 new-onset SLE patients were included, with 299 cases in the infection group and 177 cases in the noninfection group. The patients were mostly females (81.7%). The average age at diagnosis was 43.7 years. The median duration was 1.0 month. The prevalence of hypomagnesemia (&lt;0.70), normomagnesemia (0.70–1.10), and hypermagnesemia (&gt;1.10) in new-onset SLE patients was 14.3%, 83.4%, and 2.3%, respectively. The prevalence of hypomagnesemia was 18.4% in the infection group and 7.3% in the noninfection group (p = .001). The baseline value of serum magnesium was 0.819 mmol/L, with values of 0.799 mmol/L in the infection group and 0.854 mmol/L in the noninfection group (p = .000). The following clinical variables were significantly different between the two groups (p &lt; .05): age, duration, hospitalization stay, fever, serositis, and SLE Disease Activity Index 2000 (SLEDAI 2K). The laboratory parameters, including hemoglobin, white blood cell count, albumin level, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), procalcitonin, and complement C3 were also significantly different between the two groups (p &lt; .05). The mortality was 4.4% (21/476), with 20 cases occurring in the infection group. Logistic regression analysis showed that hypomagnesemia was associated with an increased risk of infection (p = .001) and poor prognosis (p = .015). Conclusion Hypermagnesemia was rare in new-onset SLE patients. Hypomagnesemia was common and was associated with an increased risk of infection in new-onset SLE patients.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>36595713</pmid><doi>10.1177/09612033221149884</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-6460-9905</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0961-2033
ispartof Lupus, 2023-03, Vol.32 (3), p.380-387
issn 0961-2033
1477-0962
language eng
recordid cdi_proquest_miscellaneous_2760818547
source SAGE:Jisc Collections:SAGE Journals Read and Publish 2023-2024: Reading List
subjects Adult
Blood Sedimentation
C-reactive protein
C-Reactive Protein - analysis
Complement component C3
Erythrocyte sedimentation rate
Female
Hemoglobin
Humans
Hypermagnesemia
Hypomagnesemia
Infections
Lupus
Lupus Erythematosus, Systemic - complications
Magnesium
Male
Procalcitonin
Regression analysis
Retrospective Studies
Serositis
Systemic lupus erythematosus
title The association of serum magnesium with infection in new-onset systemic lupus erythematosus patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A21%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20association%20of%20serum%20magnesium%20with%20infection%20in%20new-onset%20systemic%20lupus%20erythematosus%20patients&rft.jtitle=Lupus&rft.au=Yang,%20Wenfang&rft.date=2023-03&rft.volume=32&rft.issue=3&rft.spage=380&rft.epage=387&rft.pages=380-387&rft.issn=0961-2033&rft.eissn=1477-0962&rft_id=info:doi/10.1177/09612033221149884&rft_dat=%3Cproquest_cross%3E2760818547%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c368t-fe5c1af6f735bec585aaec6ee52ab6e5158986dc14b192c9e04e1f046f3f2d5e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2786441915&rft_id=info:pmid/36595713&rft_sage_id=10.1177_09612033221149884&rfr_iscdi=true